computer security, desktop security, home network, home computer, anti-virus, computer securityComputer security is on lots of peoples’ minds. And you will find plenty of companies available offering a variety of methods to stay hack proof. Most high-finish items are targeted toward large businesses. This will make sense being that they are worth millions or vast [...]
MELBOURNE, AUSTRALIA– – Genetic Technologies Limited today announced it has filed its Quarterly Activities Report and Appendix 4C for period ending December 31, 2011 in accordance with the ASX.Total cash …Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
NEW YORK, Feb. 1, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Gene Therapy – technologies, markets and companies http://www.reportlinker.com/p0203543/Gene-Therapy—technologies-markets-and-companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_TherapyGene …Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=gene+therapy&eo=UTF-8
* Shire (Stuttgart: A0MMAG – news) to pay $13 mln upfront, plus milestones * Sangamo shares rise more than 25 percent (Adds analyst comment, share price) Feb 1 (Reuters) – Pharmaceutical company Shire said on Wednesday it would collaborate with Sangamo BioSciences (Hamburg: GBY.HM – news) to develop treatments for hemophilia and other inherited diseases based on Sangamo's gene regulation and modification technology. The news, seen as a vote of confidence in Sangamo's experimental gene-disrupting technique, sent shares of the Richmond (NZSE: RHD.NZ – news) , California-based company up more than 25 percent.
01-02-2012 05:22 Specific challenges of avant-garde therapies Authorities/sponsors: being concomitantly on a learning curve Translational research: key success factors Case study: SAF-301
26-01-2012 21:26 Short Trailer on the history and applications of Gene Therapy in the modern medical scene. Written and directed by Thenmozhi Soundaranagaran Score by Keith Jackson
To the Editor: We would like to retract the article entitled “Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer,” which was published in the April 2, 2008, issue of JAMA .
Fibrocell Science, Inc. , a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announces that the June 2011 FDA approval of LAVIV™ for the improvement of the appearance of “smile line” wrinkles was named the #3 top story of 2011 in cell and gene therapy and regenerative medicine at The 2012 Cell & Gene Therapy Forum …
SAN DIEGO, Jan.
AMSTERDAM, January 30, 2012 /PRNewswire/ –Amsterdam Molecular Therapeutics (Euronext: AMT – News), a leader in the field of human gene therapy, was informed on Friday January 27, 2012 after business hours that …
23-01-2012 19:59 For Bio Honors
There are many ways to work from home and make enough money to pay your bills. You just have to find the jobs that require some credentials because these are going to pay you more money than the ones that are very easy to get. This is because the amount of people applying for them [...]
Researchers have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
Washington, Jan 24 : Researchers have developed a new gene therapy method that has the potential to treat a common form of blindness, which strikes both youngsters and adults.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=gene+therapy&eo=UTF-8
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
Putting genetic testing at the heart of the NHS could herald a "revolution" in diagnosing, treating and preventing disease, according to the government's genetics adviser.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=genetic+therapy&eo=UTF-8
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors. The discovery paves the way for a genetic screening test to determine who can safely take these drugs. The [...]
Scientists have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs. The disease in humans and dogs is caused by defects in the RPGR gene and results in early, severe and progressive vision loss. It is one of the most common inherited forms of retinal [...]
